chr16-89646032-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002768.5(CHMP1A):c.*34G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000573 in 1,601,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00041 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00059 ( 0 hom. )
Consequence
CHMP1A
NM_002768.5 3_prime_UTR
NM_002768.5 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.87
Genes affected
CHMP1A (HGNC:8740): (charged multivesicular body protein 1A) This gene encodes a member of the CHMP/Chmp family of proteins which are involved in multivesicular body sorting of proteins to the interiors of lysosomes. The initial prediction of the protein sequence encoded by this gene suggested that the encoded protein was a metallopeptidase. The nomenclature has been updated recently to reflect the correct biological function of this encoded protein. Several transcripts encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHMP1A | NM_002768.5 | c.*34G>T | 3_prime_UTR_variant | 7/7 | ENST00000397901.8 | NP_002759.2 | ||
CHMP1A | NM_001083314.4 | c.605G>T | p.Arg202Leu | missense_variant | 6/6 | NP_001076783.1 | ||
CHMP1A | XM_047434195.1 | c.*34G>T | 3_prime_UTR_variant | 7/7 | XP_047290151.1 | |||
CHMP1A | NR_046418.3 | n.913G>T | non_coding_transcript_exon_variant | 7/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHMP1A | ENST00000397901.8 | c.*34G>T | 3_prime_UTR_variant | 7/7 | 1 | NM_002768.5 | ENSP00000380998 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000414 AC: 63AN: 152204Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
63
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000520 AC: 122AN: 234644Hom.: 0 AF XY: 0.000578 AC XY: 74AN XY: 127948
GnomAD3 exomes
AF:
AC:
122
AN:
234644
Hom.:
AF XY:
AC XY:
74
AN XY:
127948
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000590 AC: 855AN: 1449100Hom.: 0 Cov.: 31 AF XY: 0.000575 AC XY: 414AN XY: 720446
GnomAD4 exome
AF:
AC:
855
AN:
1449100
Hom.:
Cov.:
31
AF XY:
AC XY:
414
AN XY:
720446
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000414 AC: 63AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.000430 AC XY: 32AN XY: 74486
GnomAD4 genome
AF:
AC:
63
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
32
AN XY:
74486
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 01, 2021 | The c.605G>T (p.R202L) alteration is located in exon 6 (coding exon 6) of the CHMP1A gene. This alteration results from a G to T substitution at nucleotide position 605, causing the arginine (R) at amino acid position 202 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at